Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Department-Specific Reviews can Streamline Material Review Workflows Leading to Faster Approvals

Organizations are increasingly adopting department-specific reviews to streamline material review workflows, eliminating unnecessary stakeholders and reducing approval times. By assigning review responsibilities to specific departments or roles, companies can clarify responsibilities, enhance regulatory adherence, and optimize efficiency. The discussion also highlights considerations for implementing this strategy, such as risk assessment and resource availability.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Vodori on MarketScale.

By Annalise Ludtke · 6 Tangerines ConsultingAnne SwearingenMaterial Review ProcessPromotional Material Review
Share
Department-Specific Reviews can Streamline Material Review Workflows Leading to Faster Approvals

Key takeaways

01

Department-specific reviews reduce approval times by clarifying responsibilities.

02

Risk assessment is crucial to determine the appropriateness of role-specific reviews.

03

The benefits include increased speed, reduced workload for reviewers, and tailored processes.

Organizations are increasingly seeking ways to streamline internal processes while ensuring compliance and maintaining high standards. One approach gaining traction is department-specific reviews or role-specific reviews. This method assigns review responsibilities to specific departments or roles, rather than having every piece of content reviewed by all departments. This strategy not only clarifies responsibilities but also ensures that only the necessary reviewers are involved in each step, optimizing efficiency and regulatory adherence.

This strategy not only clarifies responsibilities but also ensures that only the necessary reviewers are involved in each step, optimizing efficiency and regulatory adherence.

How can organizations effectively implement department-specific reviews, and what factors should be considered to determine their appropriateness?

This question is at the heart of the latest episode of “Amend & Progress by Vodori,” hosted by Annalise Ludtke and featuring Anne Swearingen, CEO of 6 Tangerines Consulting. Swearingen shares her thoughts on how organizations can streamline their review processes by implementing role-specific reviews, drawing from her extensive experience in optimizing workflow efficiencies.

Episode Highlights

  • Definition and Contextualization: Department or role-specific reviews involve assigning specific review responsibilities to certain departments or roles, rather than having every piece of content reviewed by all departments. This helps clarify who is responsible for what and ensures that only the necessary reviewers are involved in each step.
  • Risk-Based Approach: Organizations must assess the risk associated with different types of content to determine when department-specific reviews are appropriate. High-risk content, such as marketing materials with medical claims, might require comprehensive reviews, while lower-risk items, like conference invites, could be handled by a single department.
  • Benefits and Considerations: The primary benefit is increased speed, as fewer reviewers can mean faster approvals. Other benefits include reduced workload for reviewers and the ability to tailor the review process to fit the specific needs of different types of content. Organizations must consider their regulatory environment, resource availability, and internal processes when deciding how to implement these reviews.

Anne Swearingen, CEO of 6 Tangerines Consulting, brings a wealth of knowledge and experience to the discussion. With a strong background in regulatory affairs and consulting, Anne has helped numerous organizations optimize their review processes and navigate complex regulatory landscapes. Her expertise makes her a valuable voice in this conversation, offering practical advice and strategic insights.

Vodori

Part of this channel

Vodori

Faster market access through compliant life science content review.

Visit the channel

About the author

AL
Annalise Ludtke

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

AS
Anne Swearingen

CEO

6 Tangerines Consulting

Anne Swearingen, CEO of 6 Tangerines Consulting, brings a wealth of knowledge and experience to the discussion. With a strong background in regulatory affairs and consulting, Anne has helped numerous organizations optimize their review processes and navigate complex regulatory landscapes.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512